Aurobindo Pharma to ramp up generic business in western European markets: Report

05 Aug 2014 Evaluate

Aurobindo Pharma is reportedly planning to ramp up its generic business in the western European markets. While, the company has acquired about 1,250 dossiers as part of its strategy to expand in the region, it is likely to launch some more new products in the current financial year.

In addition, there were about 100 products already exported from the manufacturing units in India. The company would leverage on its large scale manufacturing capabilities in India apart from the existing European infrastructure.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.

Aurobindo Pharma Share Price

1184.55 -2.65 (-0.22%)
31-Dec-2025 09:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.90
Dr. Reddys Lab 1262.60
Cipla 1495.00
Zydus Lifesciences 908.95
Lupin 2083.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×